ARTG Entry

CENRIFKI

ARTG entry for CENRIFKI (tolebrutinib), ARTG 496226 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Sanofi-Aventis
• Active ingredient: tolebrutinib
• Therapeutic area: Neurology

TGA Public Summary — ARTG 496226